Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
2020 · Nature Communications · 45 citations
https://doi.org/10.1038/s41467-020-17552-3
A
Anna Fabiano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
500
Citations
7
h-index
6
i10-index
Anna Fabiano is an academic researcher from The San Raffaele Telethon Institute for Gene Therapy. The author has contributed to research in topics: Virus-based gene therapy research & CRISPR and Genetic Engineering & Pluripotent Stem Cells Research. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-7604-6967Papers by this author
worksEnhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes
2025 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-025-60073-0
In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking
2025 · Nature · 9 citations
https://doi.org/10.1038/s41586-025-09070-3
Identification of hepatocyte-primed cholangiocytes in the homeostatic liver by in vivo lentiviral gene transfer to mice and non-human primates
2025 · Cell Reports · 3 citations
https://doi.org/10.1016/j.celrep.2025.115341
Low-density lipoproteins receptor (LDLR) liver gene therapy normalizes LDL cholesterol (LDL-C) and prevents atherosclerosis in a familial hypercholesterolemia (FH) mouse model
2024 · Atherosclerosis · 1 citations
https://doi.org/10.1016/j.atherosclerosis.2024.118281
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat